Form D · Pharmaceuticals

SUNESIS PHARMACEUTICALS INC

South San Francisco, CA · CIK 0001061027

Offering snapshot reported Jul 14, 2010 · SEC filing

Reported sold
$28.5M
Offering amount: $28.5M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 30, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 14, 2010Initial$28,500,000No comparison18SEC filing
Apr 17, 2009Initial$10,000,000No comparisonNot reportedSEC filing
Mar 31, 2006PaperNot reportedNo comparisonNot reported

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$1.2M
Form D file number
021-144882
Placement agent fees paid in this offering to Recipient listed in Item 12.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Jefferies & Company, Inc.2347

Source: Form D, filed Jul 14, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eric H. Bjerholt Executive
Eric H. Bjerkholt Executive
Matthew K. Fust Director
Ed Hurwitz Director
Steven B. Ketchum Executive
Helen Susan Kim Director
Dayton Misfeldt Director
Homer L. Pearce Director
David C. Stump Director
Daniel N., Jr. Swisher Director, Executive
James W. Young Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
395 Oyster Point Boulevard Suite 400
South San Francisco, CA, 94080